phenyl-n-tert-butylnitrone has been researched along with Autoimmune Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, MB; Felix, CC; Hilton, G; Johnson, CP; Khanna, AK; Nilakantan, V; Pieper, GM; Roza, AM; Zhou, X | 1 |
1 other study(ies) available for phenyl-n-tert-butylnitrone and Autoimmune Diseases
| Article | Year |
|---|---|
Treatment with {alpha}-phenyl-N-tert-butylnitrone, a free radical-trapping agent, abrogates inflammatory cytokine gene expression during alloimmune activation in rat cardiac allografts.
Topics: Animals; Autoimmune Diseases; Blotting, Western; Cyclic N-Oxides; Cytokines; Down-Regulation; Electron Spin Resonance Spectroscopy; Electrophoretic Mobility Shift Assay; Free Radical Scavengers; Gene Expression; Graft Rejection; Heart Transplantation; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrogen Oxides; Nuclear Proteins; Rats; Rats, Inbred Lew; Rats, Inbred WF; Transcription Factor AP-1; Transcription Factors | 2005 |